These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 234594)

  • 1. Letter: Effects of beta-adrenergic blockade with propranolol.
    N Engl J Med; 1975 Apr; 292(14):755-6. PubMed ID: 234594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin kinetics in hypertension: effect of propranolol and penbutolol.
    Hauger-Klevene JH; Levin GM
    Medicina (B Aires); 1976; 36(3):212-8. PubMed ID: 9557
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.
    Vlaicu R; Uza G; Mărcuş C; Voinescu I
    Med Interne; 1980; 18(3):247-51. PubMed ID: 6106281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of hypertension with special reference to debrisoquine and beta blockade.
    Turner R; White P; Benton F
    Practitioner; 1976 Apr; 216(1294):431. PubMed ID: 5718
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL; Tarazi RC; Dustan HP
    N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocking agents in the treatment of hypertension.
    Stumpe KO; Kolloch RE
    Compr Ther; 1977 May; 3(5):55-65. PubMed ID: 16724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
    Bühler FR
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1798-806. PubMed ID: 13490
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blockade for hypertension.
    Drug Ther Bull; 1974 Apr; 12(9):33-5. PubMed ID: 4156667
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension].
    Minutillo S; Lupinc V; D'Agnolo B
    Minerva Med; 1979 Dec; 70(57):3919-24. PubMed ID: 43488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Tailored" application of beta-blockers in hypertension: a continuing dilemma.
    Birkenhäger WH; de Leeuw PW; Wester A; Kho TL; Vandongen R; Falke HE
    Neth J Med; 1977; 20(3):116-22. PubMed ID: 18688
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience in the treatment of hypertensive states with beta-blockaders].
    Mikhaĭlov AA; Danil'chenko MA; Zakharova AV
    Kardiologiia; 1973 Jan; 13(1):70-5. PubMed ID: 4149112
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta-blockaders in the treatment of hypertension in pregnancy].
    Kawecka-Jaszcz K; Skoczeń M
    Kardiol Pol; 1985; 28(5):334-9. PubMed ID: 2864465
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
    Bühler FR; Lütold BE
    Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of hydralazine-beta blockader association in hypertension of pregnancy].
    Monnier JC; Honore P; Lanciaux B; Boulogne M
    Lille Med; 1978; 23(9):660-6. PubMed ID: 32453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.